Catalyst Pharmaceuticals, Inc. (CPRX)
23.08
-1.80
(-7.23%)
USD |
NASDAQ |
Feb 27, 16:00
23.10
+0.02
(+0.09%)
After-Hours: 20:00
Catalyst Pharmaceuticals Research and Development Expense (TTM) : 12.71M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Ionis Pharmaceuticals, Inc. | 914.12M |
| Rigel Pharmaceuticals, Inc. | 28.24M |
| United Therapeutics Corp. | 550.00M |
| Karyopharm Therapeutics, Inc. | 125.32M |
| Krystal Biotech, Inc. | 55.08M |